964 CLINICAL BENEFIT OF SORAFENIB IN THE ELDERLY WITH ADVANCED RENAL CELL CARCINOMA: SUBGROUP ANALYSIS OF THE APPROACHES IN RENAL CANCER GLOBAL EVALUATION TRIAL (TARGETS)

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: European Urology Supplements

Abbreviated Title: European Urology Supplements

Publisher: Elsevier BV

ISSN (Print): 15699056

Publication date Created: March 2007

Publication date (Print): March 2007

Volume: 6

Issue: 2

Page: 263

Article

DOI: 10.1016/S1569-9056(07)60959-2

SO-VID: d9a9e715-ae24-45b4-a77c-5513a889c269

License:

https://www.elsevier.com/tdm/userlicense/1.0/

History

Data availability:

Comments

Comment on this article

scite_